Sponsor: Sarcoma Alliance for Research through Collaboration
Sex: All
Age: 18+
Code: NCT06942442
Phase2, Recruiting
Active & Responsive
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Clovis CA, Los Angeles CA, Newport Beach CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
Active & Responsive
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
for
Melanoma
Location: Pittsburgh PA
Sponsor: John Kirkwood
Sex: All
Age: 18+
Code: NCT06599619
Recruiting
Active & Responsive
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
for
Metastatic Melanoma
Location: Lancaster PA, Philadelphia PA, Salt Lake City UT
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT03646617
Phase2, Recruiting
Active & Responsive
Axitinib + Ipilimumab in Advanced Melanoma
for
Melanoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04996823
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
for
Uveal Neoplasms, Melanoma, Uveal
Location: Pittsburgh PA
Sponsor: Udai Kammula
Sex: All
Age: 18 - 70+
Code: NCT03467516
Phase2, Recruiting
Active & Responsive
DermaSensor Postmarket Surveillance Study
for
Melanoma, Skin
Location: New Smyrna Beach FL, Morehead City NC
Sponsor: DermaSensor, Inc.
Sex: All
Age: 40+
Code: NCT06666790
Recruiting
Active & Responsive
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for
Advanced Melanoma
Location: Chandler AZ, Hot Springs AR, Los Angeles CA,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT06697301
Phase2, Phase3, Recruiting
Active & Responsive
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
for
Uveal Melanoma, Metastatic
Location: Tampa FL
Sponsor: Modulation Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05496686
Phase1, Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Duarte CA, Glendale CA, Los Angeles CA, Murrieta CA,